Health 10 September 2026 Daily Monitor (Uganda)
Uganda Cancer Institute Discharges Second Bone Marrow Transplant Patient
The Uganda Cancer Institute (UCI) has successfully treated and discharged its second bone marrow transplant patient, Mr. David Bongomin Awany, marking a significant advancement in the nation's capacity to manage complex blood cancers. Source: https://www.monitor.co.ug/uganda/news/national/uci-discharges-second-bone-marrow-transplant-patient-5591276
The Uganda Cancer Institute (UCI) has reached another significant milestone in its fight against cancer, celebrating the successful bone marrow transplant and subsequent discharge of its second patient. Mr. David Bongomin Awany, a 56-year-old businessman, underwent an autologous stem cell transplant to treat multiple myeloma, a type of blood cancer.
Mr. Awany’s successful treatment demonstrates UCI’s growing capabilities in performing complex procedures that were previously only available abroad. He expressed his initial consideration of seeking treatment in India but ultimately chose to stay in Uganda after learning about the advancements at UCI.
“As I talk now, I am very okay. I can even dance,” Mr. Awany stated during his discharge ceremony, highlighting his positive recovery and the effectiveness of the treatment. His journey was overseen by Dr. Clement Okello, the lead transplant physician, who noted the patient’s initial severe condition, including anemia, kidney issues, and high blood pressure.
The procedure involved intensive chemotherapy to achieve remission before the transplant. Dr. Okello explained that Mr. Awany experienced minimal complications, allowing for a smooth recovery and discharge. This success follows the discharge of UCI’s first bone marrow transplant patient in April.
Minister of Health, Dr. Chris Baryomunsi, present at the discharge, lauded the achievement as a testament to sustained investment, the courage of healthcare workers, and the determination of patients. He emphasized that these advancements reduce the need for Ugandans to travel overseas for critical cancer treatments.